Previous close | 0.5234 |
Open | 0.5300 |
Bid | 0.5382 x 1100 |
Ask | 0.5572 x 200 |
Day's range | 0.5250 - 0.5896 |
52-week range | 0.2900 - 1.6700 |
Volume | |
Avg. volume | 2,356,622 |
Market cap | 116.488M |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.4800 |
Earnings date | 06 Aug 2024 - 12 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 3.50 |
Assessing Sangamo's Financial Health and Strategic Progress Amidst Challenges
Sangamo (SGMO) delivered earnings and revenue surprises of -22.73% and 94.35%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
RICHMOND, Calif., May 09, 2024--SANGAMO THERAPEUTICS REPORTS RECENT BUSINESS HIGHLIGHTS AND FIRST QUARTER 2024 FINANCIAL RESULTS